FELICIA THOMAS: Open Payments
NPI 1750844494 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 51 payments from 13 companies in 2025. Trend: 2023 $438 · 2024 $825 · 2025 $2,185
Food & beverage: $2,052Education: $133
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $634 |
| ABBVIE INC. | 12 | $379 |
| E.R. Squibb & Sons, L.L.C. | 9 | $372 |
| Axsome Therapeutics, Inc. | 8 | $326 |
| Alkermes, Inc. | 7 | $298 |
| Indivior Inc. | 2 | $39 |
| Lundbeck LLC | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $21 |
Products named: AUSTEDO XR, VRAYLAR, COBENFY, Auvelity, LYBALVI, VIVITROL, REXULTI, ARISTADA.
Industry payments across LA — which companies pay providers there.
